中國醫藥大學機構典藏 China Medical University Repository, Taiwan:Item 310903500/17663
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 29490/55136 (53%)
Visitors : 1517592      Online Users : 411
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/17663


    Title: THE NOVEL INHIBITORS FOR C-MET AND HER2/NEU
    Authors: (Y.C. Chao1);(C.L. Chen1);(K.T. Chen1);(J.L. Lin1);(Y.C. Tseng2);(S.H. Chuang3);陳語謙(Chen, Yu-Chian)
    Contributors: 生命科學院生物科技學系
    Date: 2007-03-18
    Issue Date: 2009-09-04 10:13:31 (UTC+8)
    Abstract: C-Met and Her2/neu are members of the tyrosine kinase protein family. They have a relation in many kinds of cancer. We took the templates of C-Met and Her2/neu from Protein Data Bank, and modeled the protein structures. Then, we used the software(Accerlrys) to find the ATP-binding sites to dock with several compounds. To inhibit proliferation on cells, we used the property of the compounds inhibit with ATP combine with the site to terminate phosphorylation of tyrosine kinase. After the calculation from computer, we got the interaction energy, the results show that D50300401Z01, D50300601Z01, D50306701Z01, D50307201Z01, D50308501Z01 could have lower interaction energy on C-Met and Her2/neu. And we presumed such compounds may be use for the anti-tumor agents.
    Relation: 2007 生醫年會
    Appears in Collections:[Department of Biological Science and Technology] Proceedings

    Files in This Item:

    There are no files associated with this item.



    All items in CMUR are protected by copyright, with all rights reserved.

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback